{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:44:22Z","timestamp":1793713462340,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Municipal Health Commission Youth Project","award":["20224Y0284"],"award-info":[{"award-number":["20224Y0284"]}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103911"],"award-info":[{"award-number":["82103911"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Three-year Action Plan to Strengthen the Public Health System","award":["GWVI-11.2-YQ10"],"award-info":[{"award-number":["GWVI-11.2-YQ10"]}]},{"name":"Shanghai Yangtze River Delta Scientific and Technological Innovation Community Project","award":["21002411500"],"award-info":[{"award-number":["21002411500"]}]},{"name":"Shanghai Municipal Key Clinical Specialty","award":["shslczdzk02501"],"award-info":[{"award-number":["shslczdzk02501"]}]},{"name":"Shanghai Key Laboratory of Kidney and Blood Purification","award":["20DZ2271600"],"award-info":[{"award-number":["20DZ2271600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-22924-9","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T07:36:14Z","timestamp":1746603374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of chronic kidney disease and cardiovascular disease risk with all-cause mortality: an interaction, joint and mediation analysis in Chinese adults"],"prefix":"10.1186","volume":"25","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"issue":"10075","key":"22924_CR1","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet (London England). 2017;389(10075):1238\u201352.","journal-title":"Lancet (London England)"},{"key":"22924_CR2","doi-asserted-by":"crossref","unstructured":"GBDCKDC. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet (London England). 2020;395(10225):709\u201333.","DOI":"10.1016\/S0140-6736(19)32977-0"},{"issue":"10159","key":"22924_CR3","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","unstructured":"GBD 2017 Causes of Death Collaborators. Global, regional, and National age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet (London England). 2018;392(10159):1736\u201388.","journal-title":"Lancet (London England)"},{"issue":"10159","key":"22924_CR4","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan CW, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet (London England). 2018;392(10159):2052\u201390.","journal-title":"Lancet (London England)"},{"issue":"20","key":"22924_CR5","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1161\/CIRCULATIONAHA.122.060700","volume":"146","author":"L Gaziano","year":"2022","unstructured":"Gaziano L, Sun L, Arnold M, Bell S, Cho K, Kaptoge SK, Song RJ, Burgess S, Posner DC, Mosconi K, et al. Mild-to-Moderate kidney dysfunction and cardiovascular disease: observational and Mendelian randomization analyses. Circulation. 2022;146(20):1507\u201317.","journal-title":"Circulation"},{"key":"22924_CR6","unstructured":"United States Renal Data System. The United States Renal Data System 2022 Annual Data Report. 2022."},{"issue":"1","key":"22924_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s42399-022-01347-2","volume":"5","author":"A Minciunescu","year":"2023","unstructured":"Minciunescu A, Genovese L, deFilippi C. Cardiovascular alterations and structural changes in the setting of chronic kidney disease: a review of cardiorenal syndrome type 4. SN Compr Clin Med. 2023;5(1):15.","journal-title":"SN Compr Clin Med"},{"issue":"34","key":"22924_CR8","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, Benetos A, Biffi A, Boavida JM, Capodanno D, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227\u2013337.","journal-title":"Eur Heart J"},{"key":"22924_CR9","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA, et al. The management of blood cholesterol: A report of the American college of cardiology\/american heart association task force on clinical practice guidelines. Circulation. 2019;139(25):e1082\u2013143. \/ASPC\/NLA\/PCNA Guideline on.","DOI":"10.1161\/CIR.0000000000000624"},{"key":"22924_CR10","doi-asserted-by":"crossref","unstructured":"House AA, Wanner C, Sarnak MJ, Pi\u00f1a IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGF, et al. Heart failure in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2019;95(6):1304\u201317.","DOI":"10.1016\/j.kint.2019.02.022"},{"issue":"7","key":"22924_CR11","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1681\/ASN.2019121308","volume":"31","author":"GA Nichols","year":"2020","unstructured":"Nichols GA, Ustyugova A, D\u00e9ruaz-Luyet A, O\u2019Keeffe-Rosetti M, Brodovicz KG. Health care costs by type of expenditure across eGFR stages among patients with and without diabetes, cardiovascular disease, and heart failure. J Am Soc Nephrology: JASN. 2020;31(7):1594\u2013601.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"7","key":"22924_CR12","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1681\/ASN.2005101085","volume":"17","author":"M Tonelli","year":"2006","unstructured":"Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrology: JASN. 2006;17(7):2034\u201347.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"1","key":"22924_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/0886022X.2019.1595646","volume":"41","author":"XR Wang","year":"2019","unstructured":"Wang XR, Zhang JJ, Xu XX, Wu YG. Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis. Ren Fail. 2019;41(1):244\u201356.","journal-title":"Ren Fail"},{"issue":"25","key":"22924_CR14","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"22924_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/j.1467-789X.2012.01016.x","volume":"13","author":"S Yan","year":"2012","unstructured":"Yan S, Li J, Li S, Zhang B, Du S, Gordon-Larsen P, Adair L, Popkin B. The expanding burden of cardiometabolic risk in China: the China health and nutrition survey. Obes Reviews: Official J Int Association Study Obes. 2012;13(9):810\u201321.","journal-title":"Obes Reviews: Official J Int Association Study Obes"},{"key":"22924_CR16","unstructured":"Kidney Disease. Improving global outcomes (KDIGO) CKD work group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Supplements 2013(3):1\u2013150."},{"issue":"11","key":"22924_CR17","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0828-282X(06)70310-5","volume":"22","author":"R McPherson","year":"2006","unstructured":"McPherson R, Frohlich J, Fodor G, Genest J, Canadian Cardiovascular S. Canadian cardiovascular society position statement\u2013recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol. 2006;22(11):913\u201327.","journal-title":"Can J Cardiol"},{"issue":"18","key":"22924_CR18","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837\u201347.","journal-title":"Circulation"},{"issue":"8","key":"22924_CR19","first-page":"3182","volume":"27","author":"TC Turin","year":"2012","unstructured":"Turin TC, Tonelli M, Manns BJ, Ravani P, Ahmed SB, Hemmelgarn BR. Chronic kidney disease and life expectancy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and transplant association -. Eur Ren Association. 2012;27(8):3182\u20136.","journal-title":"Eur Ren Association"},{"issue":"9854","key":"22924_CR20","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/S0140-6736(12)61272-0","volume":"380","author":"BK Mahmoodi","year":"2012","unstructured":"Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (London England). 2012;380(9854):1649\u201361.","journal-title":"Lancet (London England)"},{"issue":"9854","key":"22924_CR21","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","volume":"380","author":"CS Fox","year":"2012","unstructured":"Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (London England). 2012;380(9854):1662\u201373.","journal-title":"Lancet (London England)"},{"key":"22924_CR22","doi-asserted-by":"crossref","unstructured":"Korhonen PE, Kiiski S, Kautiainen H, Ojanen S, Tertti R. The relationship of kidney function, cardiovascular morbidity, and All-Cause mortality: a prospective primary care cohort study. Journal of general internal medicine 2022.","DOI":"10.1007\/s11606-022-07885-8"},{"issue":"11","key":"22924_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","volume":"18","author":"K Matsushita","year":"2022","unstructured":"Matsushita K, Ballew SH, Wang AY, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18(11):696\u2013707.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"22924_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11886-021-01546-8","volume":"23","author":"LJ Laffin","year":"2021","unstructured":"Laffin LJ, Bakris GL. Intersection between chronic kidney disease and cardiovascular disease. Curr Cardiol Rep. 2021;23(9):117.","journal-title":"Curr Cardiol Rep"},{"issue":"6","key":"22924_CR25","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/ije\/dyab203","volume":"50","author":"J Zheng","year":"2022","unstructured":"Zheng J, Zhang Y, Rasheed H, Walker V, Sugawara Y, Li J, Leng Y, Elsworth B, Wootton RE, Fang S, et al. Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease. Int J Epidemiol. 2022;50(6):1995\u20132010.","journal-title":"Int J Epidemiol"},{"key":"22924_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2021.09.007","volume":"335","author":"Y Mok","year":"2021","unstructured":"Mok Y, Ballew SH, Matsushita K. Chronic kidney disease measures for cardiovascular risk prediction. Atherosclerosis. 2021;335:110\u20138.","journal-title":"Atherosclerosis"},{"issue":"8","key":"22924_CR27","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","volume":"132","author":"M Burnier","year":"2023","unstructured":"Burnier M, Damianaki A. Hypertension as cardiovascular risk factor in chronic kidney disease. Circul Res. 2023;132(8):1050\u201363.","journal-title":"Circul Res"},{"key":"22924_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/5584_2016_84","volume":"956","author":"SM Hamrahian","year":"2017","unstructured":"Hamrahian SM, Falkner B. Hypertension in chronic kidney disease. Adv Exp Med Biol. 2017;956:307\u201325.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"22924_CR29","doi-asserted-by":"publisher","first-page":"e74058","DOI":"10.1371\/journal.pone.0074058","volume":"8","author":"S Chen","year":"2013","unstructured":"Chen S, Chen Y, Liu X, Li M, Wu B, Li Y, Liang Y, Shao X, Holth\u00f6fer H, Zou H. Association of insulin resistance with chronic kidney disease in non-diabetic subjects with normal weight. PLoS ONE. 2013;8(9):e74058.","journal-title":"PLoS ONE"},{"issue":"6","key":"22924_CR30","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Ren Physiol. 2016;311(6):F1087\u2013108.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"5","key":"22924_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7861\/clinmedicine.10-5-505","volume":"10","author":"K Vithian","year":"2010","unstructured":"Vithian K, Hurel S. Microvascular complications: pathophysiology and management. Clin Med. 2010;10(5):505\u20139.","journal-title":"Clin Med"},{"issue":"1","key":"22924_CR32","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1038\/s41598-023-29844-x","volume":"13","author":"H Ryu","year":"2023","unstructured":"Ryu H, Hong Y, Kang E, Kang M, Kim J, Park HC, Oh YK, Chin HJ, Park SK, Jung JY, et al. Comparison of outcomes of chronic kidney disease based on etiology: a prospective cohort study from KNOW-CKD. Sci Rep. 2023;13(1):3570.","journal-title":"Sci Rep"},{"key":"22924_CR33","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes CKD-MBD Update Work Group: KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. (2011) 2017, 7(1):1\u201359.","DOI":"10.1016\/j.kisu.2017.04.001"},{"issue":"11","key":"22924_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"SC Palmer","year":"2011","unstructured":"Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011;305(11):1119\u201327.","journal-title":"JAMA"},{"issue":"6","key":"22924_CR35","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.ekir.2017.07.001","volume":"2","author":"PH Pun","year":"2017","unstructured":"Pun PH, Goldstein BA, Gallis JA, Middleton JP, Svetkey LP. Serum potassium levels and risk of sudden cardiac death among patients with chronic kidney disease and significant coronary artery disease. Kidney Int Rep. 2017;2(6):1122\u201331.","journal-title":"Kidney Int Rep"},{"issue":"2","key":"22924_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00467-017-3663-y","volume":"33","author":"MA Atkinson","year":"2018","unstructured":"Atkinson MA, Warady BA. Anemia in chronic kidney disease. Pediatr Nephrol. 2018;33(2):227\u201338.","journal-title":"Pediatr Nephrol"},{"key":"22924_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1523-1755.61.s80.7.x","volume":"80","author":"A Levin","year":"2002","unstructured":"Levin A. Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Supplement. 2002;80:35\u20138.","journal-title":"Kidney Int Supplement"},{"issue":"7","key":"22924_CR38","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1681\/ASN.2013080899","volume":"25","author":"QZ Cai","year":"2014","unstructured":"Cai QZ, Lu XZ, Lu Y, Wang AY. Longitudinal changes of cardiac structure and function in CKD (CASCADE study). J Am Soc Nephrology: JASN. 2014;25(7):1599\u2013608.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"6","key":"22924_CR39","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrneph.2017.52","volume":"13","author":"C Zoccali","year":"2017","unstructured":"Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, et al. The systemic nature of CKD. Nat Rev Nephrol. 2017;13(6):344\u201358.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"22924_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000351758","volume":"38","author":"H Moradi","year":"2013","unstructured":"Moradi H, Sica DA, Kalantar-Zadeh K. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease. Am J Nephrol. 2013;38(2):136\u201348.","journal-title":"Am J Nephrol"},{"issue":"1","key":"22924_CR41","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.kint.2020.08.012","volume":"99","author":"K Ueki","year":"2021","unstructured":"Ueki K, Sasako T, Okazaki Y, Miyake K, Nangaku M, Ohashi Y, Noda M, Kadowaki T. Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes. Kidney Int. 2021;99(1):256\u201366.","journal-title":"Kidney Int"},{"issue":"3","key":"22924_CR42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","volume":"99","author":"AK Cheung","year":"2021","unstructured":"Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, Knoll GA, Muntner P, Pecoits-Filho R, Sarnak MJ, et al. Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3):559\u201369.","journal-title":"Kidney Int"},{"issue":"4","key":"22924_CR43","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.kint.2020.06.024","volume":"98","author":"IH de Boer","year":"2020","unstructured":"de Boer IH, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K, Liew A, Michos ED, Navaneethan SD, Olowu WA, et al. Executive summary of the 2020 KDIGO diabetes management in CKD guideline: evidence-based advances in monitoring and treatment. Kidney Int. 2020;98(4):839\u201348.","journal-title":"Kidney Int"},{"key":"22924_CR44","doi-asserted-by":"crossref","unstructured":"Kitamura H, Tanaka S, Hiyamuta H, Shimamoto S, Tsuruya K, Nakano T, Kitazono T. Cardiovascular risk factor burden and treatment control in patients with chronic kidney disease: A Cross-Sectional study. Journal of atherosclerosis and thrombosis 2022.","DOI":"10.1681\/ASN.20223311S1219d"},{"issue":"5","key":"22924_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","volume":"17","author":"RA DeFronzo","year":"2021","unstructured":"DeFronzo RA, Reeves WB, Awad AS. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat Rev Nephrol. 2021;17(5):319\u201334.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"22924_CR46","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/dom.13648","volume":"21","author":"T Toyama","year":"2019","unstructured":"Toyama T, Neuen BL, Jun M, Ohkuma T, Neal B, Jardine MJ, Heerspink HL, Wong MG, Ninomiya T, Wada T, et al. Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis. Diabetes Obes Metab. 2019;21(5):1237\u201350.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"22924_CR47","doi-asserted-by":"publisher","first-page":"e14061","DOI":"10.1111\/ctr.14061","volume":"34","author":"J Junarta","year":"2020","unstructured":"Junarta J, Fernandez M, Chung I, Salha A, Klaud Francheska BD, Lowe-Jones R, Sharma R, Firoozi S, Banerjee D. Role of a cardio-renal multi-disciplinary team meeting in managing cardiovascular risk in patients on kidney transplant waitlists. Clin Transplant. 2020;34(11):e14061.","journal-title":"Clin Transplant"},{"issue":"2","key":"22924_CR48","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3109\/0886022X.2014.982489","volume":"37","author":"S Lai","year":"2015","unstructured":"Lai S, Dimko M, Galani A, Coppola B, Innico G, Frassetti N, Mazzei ED, Mariotti A. Early markers of cardiovascular risk in chronic kidney disease. Ren Fail. 2015;37(2):254\u201361.","journal-title":"Ren Fail"},{"issue":"14","key":"22924_CR49","first-page":"1401","volume":"323","author":"MJ Stensrud","year":"2020","unstructured":"Stensrud MJ, Hern\u00e1n MA. Why Test Proportional Hazards? Jama. 2020;323(14):1401\u20132.","journal-title":"Why Test Proportional Hazards? Jama"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22924-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22924-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22924-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:05:38Z","timestamp":1746608738000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22924-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22924"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22924-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"8 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants. CHNS was approved by the Institutional Review Board (IRB) at the University of North Carolina at Chapel Hill and local IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1685"}}